(Q51076629)

28 March 2018

title

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. (English)

1 reference

28 March 2018

0 references

1 reference

Adelman LC

1

1 reference

28 March 2018

Adelman JU

series ordinal

2

1 reference

28 March 2018

Von Seggern R

series ordinal

3

1 reference

28 March 2018

Mannix LK

series ordinal

4

1 reference

28 March 2018

publication date

1 July 2000

1 reference

28 March 2018

published in

Headache

1 reference

28 March 2018

volume

40

1 reference

28 March 2018

issue

7

1 reference

28 March 2018

page(s)

572-580

1 reference

28 March 2018

Migraine prophylactic drugs: proof of efficacy, utilization and cost

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

TREATMENT OF CHRONIC TENSION HEADACHE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Preventive treatment of migraine: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Fluoxetine prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Paroxetine in the treatment of chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Venlafaxine: a structurally unique and novel antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Binding of antidepressants to human brain receptors: focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

How do the currently used prophylactic agents work in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Neuropathic pain of peripheral origin: advances in pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Comprehensive management of headache and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00089.X

10.1046/J.1526-4610.2000.00089.X

21 January 2018

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018